testosterone undecanoate has been researched along with androstane-3,17-diol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, DC; Cantrill, JA; Dewis, P; Large, DM; Newman, M | 1 |
Deslypere, JP; Giagulli, VA; Giorgino, R; Verdonck, L; Vermeulen, A | 1 |
Bäckström, T; Carlström, K; Hirschberg, AL; Kocoska-Maras, L; Rådestad, AF; von Schoultz, B | 1 |
1 trial(s) available for testosterone undecanoate and androstane-3,17-diol
Article | Year |
---|---|
Cognitive function in association with sex hormones in postmenopausal women.
Topics: Androgens; Androstane-3,17-diol; Cognition; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Memory; Middle Aged; Neuropsychological Tests; Oxytocin; Placebos; Postmenopause; Testosterone; Verbal Learning | 2013 |
2 other study(ies) available for testosterone undecanoate and androstane-3,17-diol
Article | Year |
---|---|
Which testosterone replacement therapy?
Topics: Administration, Oral; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 1984 |
Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Androstane-3,17-diol; Dihydrotestosterone; Humans; Male; Middle Aged; Splanchnic Circulation; Testosterone | 1993 |